Exane Derivatives’s iShares S&P 500 Value ETF IVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-52,550
Closed -$8.23M 1051
2021
Q4
$8.23M Buy
52,550
+44,148
+525% +$6.71M 1.99% 6
2021
Q3
$1.22M Sell
8,402
-50,572
-86% -$7.54M 0.29% 71
2021
Q2
$8.73M Buy
58,974
+23,528
+66% +$3.47M 1.98% 4
2021
Q1
$5.01M Buy
+35,446
New +$4.77M 1.43% 11

Other funds holding IVE

Exane Derivatives's IVE Position: Q1 2022 in Review

Exane Derivatives sold out of iShares S&P 500 Value ETF (IVE) in Q1 2022, closing a stake of 52,550 shares — an estimated $8.23M sold.

Exane Derivatives first reported a position in IVE in Q1 2021 and held it in 4 quarters. The position peaked at $8.73M in Q2 2021. 1,073 funds tracked by Wall St. Rank hold IVE as of Q1 2022.

  • Exane Derivatives reported no remaining iShares S&P 500 Value ETF position as of Q1 2022 after selling out during the quarter.
  • Exane Derivatives sold 52,550 iShares S&P 500 Value ETF shares in Q1 2022, an estimated $8.23M.
  • Exane Derivatives first reported a position in iShares S&P 500 Value ETF in Q1 2021 and held it in 4 quarters.
  • Exane Derivatives's iShares S&P 500 Value ETF position peaked at $8.73M in Q2 2021.
  • 1,073 funds tracked by Wall St. Rank held iShares S&P 500 Value ETF as of Q1 2022.

Based on Exane Derivatives's 13F filing for Q1 2022, filed 22 Apr 2022.